The Patent Finder

Pharmaceutical Compositions Comprising Fesoterodine

Ucb Pharma S.A.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 60/812,149, filed Jun 9, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 7,807,715Pharmaceutical Compositions Comprising Fesoterodine
In force
 · High confidence
UsedRemaining
Ucb Pharma GmbHIn forceHigh confidence
US 9,364,541Pharmaceutical Compositions Comprising Fesoterodine
In force
 · Medium confidence
Ucb Pharma GmbHIn forceMedium confidence
US 8,088,398Pharmaceutical Compositions Comprising Fesoterodine
In force
 · Medium confidence
Ucb Pharma GmbHIn forceMedium confidence
US 8,501,723Pharmaceutical Compositions Comprising Fesoterodine
In force
 · Medium confidence
Ucb Pharma GmbHIn forceMedium confidence
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited